Our Team

Board of Directors and Advisors

Archbishop Xuereb served as first private secretary of Pope Francis. Before being selected, he had served, next to the private secretary Georg Ganswein, as second private secretary of Pope Benedict XVI. 

Since 2000 he served in the Prefecture of the Papal Household. Pope John Paul II awarded him on 9 September 2003 the Papal title of Honorary Prelate. In 2007, Pope Benedict XVI appointed Xuereb as his second private secretary. He accompanied the Pope on his trips. After the election of Pope Francis in 2013, Xuereb became his first private secretary. On 3 March 2014, Pope Francis appointed him the first Prelate Secretary of the Secretariat for the Economy.


Master Hao

Master Hao was invited to the USA as person of extraordinary abilities and those who are the most capable and accomplished in their professional fields. 

Master Hao's specialty is non-invasive alternative treatment for cancer. Mas Hao has treated many cancer patients successfully with alternative means, such as food dietary,  physical exercise, mental meditation, etc.   Master patients includes teenagers, adults, and seniors alike, with various forms of cancer at different stages.  Master Hao customized her treatment for each cancer patient, with years of care and treatment for free.



Ying-Chu Shih, Ph.D., Board of Director Chair of Taiwan Pharma.

Dr. Shih is Chair of Board of Directors of Taiwan Pharmaceuticals Co. which is a specialty pharmaceutical company dedicated to the development and commercialization of small molecules for unmet medical needs such as chronic organ inflammation of metabolic, autoimmune and infectious etiologies. In addition, novel steroid-sparing therapies for allergy/asthma are being pursued.

Dr. Shih specialized in the pharmaceutical research and early drug development in immunology, for diseases such as asthma, rheumatoid arthritis, liver diseases, and related areas. She worked as a research fellow, project leader, and project manager and as a director coordinating a team of 25 staff at ITRI, a leading biomedical R&D institution in Taiwan.


Ms. Zhang, LAc.

Ms. Zhang is a Licensed Acupuncturist in Traditional Chinese Medicine (TCM) and Professor at University of East & West Medicine.  Ms. Zhang has twenty-seven years of clinical experiences in TCM, and served as the Chief Physician at the prestigious Beijing Tong Ren Hospital prior to extending her practice here in USA. Ms. Zhang also serve as the Associate Professor for ten years at the Beijing Capital Medical University; and upon coming to the USA in 1999, as the Professor and Clinic Faculty at the University of East & West Medicine.

Ms. Zhang graduated from the most prestigious Beijing University of Chinese Medicine, and is a member of the Chinese Medical Association and commissioner in Traditional Medicine specialists of Diabetes. Additionally, she is also the commissioner in specialists of Diabetes of Beijing Chinese Traditional Medicine Council.


Kenneth Ericksen 

Mr. Ericksen has over thirty years of experience in area of Emergency Management.  Mr. Ericksen served  the City of Cupertino for the  Community Emergency Response Team (CERT), Cupertino Amateur Radio Emergency Services (CARES), and the Medical Response Corp (MRC) program as well as EMT for County of Santa Clara.


Read more

Gallery

Diagnosis, Research, Treatment; Food & Drug Administration (FDA)

World Health Organization (WHO), Industrial Technology Research Inst. (ITRI)

Research

UN WHO

USA FDA

Diagnosis

ITRI

Treatment


Help Us to Help You

We freely donate the cancer drug to the World Health Organization of the United Nations upon FDA approval.

How much does it cost to get a drug through the FDA?

According to the Journal of the American Medical Association (JAMA) Internal Medicine, researchers from John Hopkins found the average total cost of Clinical trials that support FDA approvals of a new drug, which in recent years has been estimated at between $2 to $3 billion.

Follow Us

Live Long and Prosper